1-12 of 12
Li Zhu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exposure–Response Analysis to Support Nivolumab Once Every 4 Weeks Dosing in Combination with Cabozantinib in Renal Cell Carcinoma

Lora Hamuro, Zheyi Hu, Julie Passarell, Heather Barcomb, Joshua Zhang, Shay Goldstein, Akintunde Bello, Amit Roy, Li Zhu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1603–1613.
https://doi.org/10.1158/1078-0432.CCR-21-3149
Published: 14 April 2022
View article titled, Exposure–Response Analysis to Support Nivolumab Once Every 4 Weeks Dosing in Combination with Cabozantinib in Renal Cell Carcinoma
Open the PDF for Exposure–Response Analysis to Support Nivolumab Once Every 4 Weeks Dosing in Combination with Cabozantinib in Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis

Li-Peng Hu, Xiao-Xin Zhang, Shu-Heng Jiang, Ling-Ye Tao, Qing Li, Li-Li Zhu, Ming-Wei Yang, Yan-Miao Huo, Yong-Sheng Jiang, Guang-Ang Tian, Xiao-Yan Cao, Yan-Li Zhang, Qin Yang, Xiao-Mei Yang, Ya-Hui Wang, Jun Li, Gary Guishan Xiao, Yong-Wei Sun, Zhi-Gang Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1318–1330.
https://doi.org/10.1158/1078-0432.CCR-18-2297
Published: 15 February 2019
View article titled, Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis
Open the PDF for Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis in another window
Includes: Supplementary data
Journal Articles

Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents

Allan Lipton, Matthew R. Smith, Karim Fizazi, Alison T. Stopeck, David Henry, Janet E. Brown, Neal D. Shore, Fred Saad, Andrew Spencer, Li Zhu, Douglas J. Warner
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (23): 5713–5721.
https://doi.org/10.1158/1078-0432.CCR-15-3086
Published: 30 November 2016
View article titled, Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents
Open the PDF for Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents in another window
Includes: Supplementary data
Journal Articles

Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells

Le Xuan Truong Nguyen, Li Zhu, Yunqin Lee, Lynn Ta, Beverly S. Mitchell
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (13): 3320–3327.
https://doi.org/10.1158/1078-0432.CCR-15-2282
Published: 30 June 2016
View article titled, Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells
Open the PDF for Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells in another window
Includes: Supplementary data
Journal Articles

Role of CXCR3 Ligands in IL-7/IL-7Rα-Fc–Mediated Antitumor Activity in Lung Cancer

Åsa Andersson, Minu K. Srivastava, Marni Harris-White, Min Huang, Li Zhu, David Elashoff, Robert M. Strieter, Steven M. Dubinett, Sherven Sharma
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (11): 3660–3672.
https://doi.org/10.1158/1078-0432.CCR-10-3346
Published: 01 June 2011
View article titled, Role of CXCR3 Ligands in IL-7/IL-7Rα-Fc–Mediated Antitumor Activity in Lung Cancer
Open the PDF for Role of CXCR3 Ligands in IL-7/IL-7Rα-Fc–Mediated Antitumor Activity in Lung Cancer in another window
Journal Articles

Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell Carcinoma

Maie A. St. John, Mariam Dohadwala, Jie Luo, Guanyu Wang, Gina Lee, Hubert Shih, Eileen Heinrich, Kostantyn Krysan, Tonya Walser, Saswati Hazra, Li Zhu, Chi Lai, Elliot Abemayor, Michael Fishbein, David A. Elashoff, Sherven Sharma, Steven M. Dubinett
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6018–6027.
https://doi.org/10.1158/1078-0432.CCR-09-0011
Published: 30 September 2009
View article titled, Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell Carcinoma
Open the PDF for Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell Carcinoma in another window
Journal Articles

Reduced Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines Correlates with Mutations Affecting the COOH-Terminal Nuclear Localization Signal of p53

Robert Mandic, Chantal J. Schamberger, Julia F. Müller, Matthias Geyer, Li Zhu, Thomas E. Carey, Reidar Grénman, Anja A. Dünne, Jochen A. Werner
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 6845–6852.
https://doi.org/10.1158/1078-0432.CCR-05-0378
Published: 03 October 2005
View article titled, Reduced Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines Correlates with Mutations Affecting the COOH-Terminal Nuclear Localization Signal of p53
Open the PDF for Reduced Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines Correlates with Mutations Affecting the COOH-Terminal Nuclear Localization Signal of p53 in another window
Journal Articles

CXCR4 and CXCL12 (SDF-1) in Prostate Cancer: Inhibitory Effects of Human Single Chain Fv Antibodies

Gayle G. Vaday, Shao-Bing Hua, Donna M. Peehl, Michelle H. Pauling, Yu-Huei Lin, Li Zhu, Diana M. Lawrence, Hussein D. Foda, Stanley Zucker
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5630–5639.
https://doi.org/10.1158/1078-0432.CCR-03-0633
Published: 24 August 2004
View article titled, CXCR4 and CXCL12 (SDF-1) in Prostate Cancer: <subtitle>Inhibitory Effects of Human Single Chain Fv Antibodies</subtitle>
Open the PDF for CXCR4 and CXCL12 (SDF-1) in Prostate Cancer: <subtitle>Inhibitory Effects of Human Single Chain Fv Antibodies</subtitle> in another window
Journal Articles

Her2/neu Expression Predicts the Response to Antiaromatase Neoadjuvant Therapy in Primary Breast Cancer: Subgroup Analysis from Celecoxib Antiaromatase Neoadjuvant Trial

Li Zhu, Louis W. C. Chow, Wings T. Y. Loo, Xin-Yuan Guan, Mazakazu Toi
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4639–4644.
https://doi.org/10.1158/1078-0432.CCR-04-0057
Published: 21 July 2004
View article titled, Her2/neu Expression Predicts the Response to Antiaromatase Neoadjuvant Therapy in Primary Breast Cancer: <subtitle>Subgroup Analysis from Celecoxib Antiaromatase Neoadjuvant Trial</subtitle>
Open the PDF for Her2/neu Expression Predicts the Response to Antiaromatase Neoadjuvant Therapy in Primary Breast Cancer: <subtitle>Subgroup Analysis from Celecoxib Antiaromatase Neoadjuvant Trial</subtitle> in another window
Journal Articles

Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity

Seok-Chul Yang, Sven Hillinger, Karen Riedl, Ling Zhang, Li Zhu, Min Huang, Kimberly Atianzar, Brian Y. Kuo, Brian Gardner, Raj K. Batra, Robert M. Strieter, Steven M. Dubinett, Sherven Sharma
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (8): 2891–2901.
https://doi.org/10.1158/1078-0432.CCR-03-0380
Published: 20 April 2004
View article titled, Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity
Open the PDF for Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity in another window
Journal Articles

Celecoxib Modulates the Capacity for Prostaglandin E2 and Interleukin-10 Production in Alveolar Macrophages from Active Smokers

Jenny T. Mao, Michael D. Roth, Kenneth J. Serio, Felicita Baratelli, Li Zhu, E. Carmack Holmes, Robert M. Strieter, Steven M. Dubinett
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5835–5841.
Published: 15 December 2003
View article titled, Celecoxib Modulates the Capacity for Prostaglandin E<sub>2</sub> and Interleukin-10 Production in Alveolar Macrophages from Active Smokers
Open the PDF for Celecoxib Modulates the Capacity for Prostaglandin E<sub>2</sub> and Interleukin-10 Production in Alveolar Macrophages from Active Smokers in another window
Journal Articles

Tumor Cyclooxygenase 2-dependent Suppression of Dendritic Cell Function

Sherven Sharma, Marina Stolina, Seok-Chul Yang, Felicita Baratelli, Jeff F. Lin, Kimberly Atianzar, Jie Luo, Li Zhu, Ying Lin, Min Huang, Mariam Dohadwala, Raj K. Batra, Steven M. Dubinett
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (3): 961–968.
Published: 01 March 2003
View article titled, Tumor Cyclooxygenase 2-dependent Suppression of Dendritic Cell Function
Open the PDF for Tumor Cyclooxygenase 2-dependent Suppression of Dendritic Cell Function in another window